Cilazapril is an angiotensin-converting enzyme (ACE) inhibitor utilized for the management of mild-to-moderate hypertension and congestive heart failure. As a prodrug, it undergoes in vivo metabolism into… Read more








Cilazapril is an angiotensin-converting enzyme (ACE) inhibitor utilized for the management of mild-to-moderate hypertension and congestive heart failure. As a prodrug, it undergoes in vivo metabolism into its active form, cilazaprilat. To support rigorous analytical testing, method validation, and quality control, laboratories rely on a comprehensive range of related compounds. This category includes high-quality reference standards of the active pharmaceutical ingredient, alongside its pharmacopeial and non-pharmacopeial impurities, such as N-nitroso derivatives, stereoisomers, and various ethyl esters. Additionally, stable isotope-labelled compounds are essential for accurate quantification in complex matrices during stability studies and impurity profiling. Utilizing these precise materials ensures compliance with regulatory requirements and provides the necessary reliability for drug development and routine pharmaceutical analysis.